(Q33539734)

27 July 2017

1 reference

title

Lack of evidence for systemic toxicity following topical chloramphenicol use. (English)

1 reference

27 July 2017

1 reference

Walker S

1

1 reference

27 July 2017

Diaper CJ

2

1 reference

27 July 2017

Bowman R

3

1 reference

27 July 2017

Sweeney G

4

1 reference

27 July 2017

Seal DV

5

1 reference

27 July 2017

Kirkness CM

6

1 reference

27 July 2017

publication date

1 January 1998

1 reference

27 July 2017

number of pages

5

1 reference

inferred from page(s)

published in

Eye

1 reference

27 July 2017

volume

12 ( Pt 5)

1 reference

27 July 2017

page(s)

875-879

1 reference

Tetracyclines, Chloramphenicol, Erythromycin, Clindamycin, and Metronidazole

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Ocular penetration of topical chloramphenicol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Use of chloramphenicol as topical eye medication: time to cry halt?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

A CONTROLLED DOUBLE-BLIND STUDY OF THE HEMATOLOGIC TOXICITY OF CHLORAMPHENICOL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

The pathophysiology of acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Letter: Chloramphenicol eye-drops and marrow aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Marrow aplasia following topical application of chloramphenicol eye ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Adult pure red cell aplasia following topical ocular chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Statewide study of chloramphenicol therapy and fatal aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Is it time to stop using chloramphenicol on the eye? Risk is low in short courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Widespread use of topical chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Pharmacokinetics of topically applied ophthalmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Systemic absorption of topically applied chloramphenicol eyedrops

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anaemia should give definitive answer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

Penetration of chloramphenicol U.S.P. (chloromycetin) into the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Chloramphenicol in Aqueous Humor After Topical Application

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Stable Chloramphenicol Solution for Ocular Infections

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Topical chloramphenicol: use or abuse?

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Current position of chloramphenicol chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Blood dyscrasias and topical ophthalmic chloramphenicol

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Aplastic anemia and chloramphenicol

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Diverse effects of anti-CD44 antibodies on the stromal cell-mediated support of normal but not leukaemic (CML) haemopoiesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Blood dyscrasias and topically applied chloramphenicol in ophthalmology

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.221

7 January 2021

Identifiers

DOI

10.1038/EYE.1998.221

1 reference

Dimensions Publication ID

27 July 2017

1020001270

0 references

1 reference